Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellit (Q46963862)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2007

Language	Label	Description	Also known as
English	Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellit	scientific article published in August 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

0 references

Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellit (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

type-1 diabetes

0 references

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

meta-regression

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

glycated hemoglobin

1 reference

object named as

glycosylated hemoglobin

23 October 2023

based on heuristic

inferred from title

Hannele Yki-Järvinen

3

object named as

Hannele Yki-Jarvinen

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

Hans-Ulrich Häring

5

object named as

Hans-Ulrich Haring

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

author name string

Peter Mullins

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

Peter Sharplin

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

Matthew C Riddle

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

publication date

1 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

29

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

1607-1619

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

When oral agents fail: practical barriers to starting insulin

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Hypoglycemia as a barrier to glycemic control

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Resource utilization and costs of care in the diabetes control and complications trial

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Making the transition from oral to insulin therapy

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

What is the proper use of hemoglobin A1c monitoring in the elderly?

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Once-daily insulin glargine compared with twice-daily NPH insulin in patients with type 1 diabetes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CLINTHERA.2007.08.020

Identifiers

10.1016/J.CLINTHERA.2007.08.020

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17919543

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46963862&oldid=1996034189"